Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vijaypd CeuticalNSE:VIJAYPD -6.99%14 Return-on-Tangible-Asset is 6.89% as of Mar. 2026, which is 18% above its 10-year median of 5.83. GuruFocus rates NSE:VIJAYPD with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Vijaypd Ceutical ranks better than 54.19% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Vijaypd Ceutical's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹51.7 Mil. Vijaypd Ceutical's average total tangible assets for the quarter that ended in Mar. 2026 was ₹750.1 Mil. Therefore, Vijaypd Ceutical's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 6.89%.
The historical rank and industry rank for Vijaypd Ceutical's Return-on-Tangible-Asset or its related term are showing as below:
NSE:VIJAYPD'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.55 Med: 5.83 Max: 11.07
Current: 3.45
During the past 4 years, Vijaypd Ceutical's highest Return-on-Tangible-Asset was 11.07%. The lowest was 0.55%. And the median was 5.83%.
NSE:VIJAYPD's Return-on-Tangible-Asset is ranked better than 54.19% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 2.59
vs NSE:VIJAYPD: 3.45
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Vijaypd Ceutical Return-on-Tangible-Asset Related Terms
Vijaypd Ceutical Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Vijaypd Ceutical's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Vijaypd Ceutical's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaypd Ceutical Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vijaypd Ceutical's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Vijaypd Ceutical's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.89% mean?
Vijaypd Ceutical (NSE:VIJAYPD) has a Return-on-Tangible-Asset of 6.89% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Vijaypd Ceutical and its competitors. This is 18% above median its historical median of 5.83. Over the past decade, Vijaypd Ceutical's Return-on-Tangible-Asset has ranged from 0.55 to 11.07. According to the industry distribution chart, Vijaypd Ceutical ranks #312 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 45.8%.
Is Vijaypd Ceutical's Return-on-Tangible-Asset too high?
Vijaypd Ceutical's current Return-on-Tangible-Asset of 6.89% is 18% above median its 10-year median of 5.83. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 11.07. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.59. Vijaypd Ceutical's value of 6.89% is 166% above this industry median. Based on the distribution chart, Vijaypd Ceutical ranks #312 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Vijaypd Ceutical has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Vijaypd Ceutical's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Vijaypd Ceutical ranks #312 out of 681 companies for Return-on-Tangible-Asset. This puts Vijaypd Ceutical in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.59. Vijaypd Ceutical's value of 6.89% is 166% above this benchmark. Historically, Vijaypd Ceutical's own Return-on-Tangible-Asset has ranged from 0.55 to 11.07 over the past decade. While the company's 10-year median is 5.83 vs. the industry median of 2.59, Vijaypd Ceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.59, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vijaypd Ceutical's current Return-on-Tangible-Asset of 6.89% is 166% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Vijaypd Ceutical and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vijaypd Ceutical's current Return-on-Tangible-Asset is 6.89%, which is 18% above median its own 10-year median of 5.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaypd Ceutical stock overvalued right now?
Vijaypd Ceutical (NSE:VIJAYPD) has a current Return-on-Tangible-Asset of 6.89%. The current Return-on-Tangible-Asset is 6.89%, which is 18% above median its 10-year median of 5.83 and 166% above the Healthcare Providers & Services industry median of 2.59. Vijaypd Ceutical's overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Vijaypd Ceutical (NSE:VIJAYPD), the current Return-on-Tangible-Asset is 6.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vijaypd Ceutical Ltd is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. The company offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supply vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits.
14GF Score
Get the complete analysis for NSE:VIJAYPD
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VIJAYPD has been successfully added to your 
